Zygomycosis: conventional laboratory diagnosis

被引:114
作者
Lass-Floerl, C. [1 ]
机构
[1] Innsbruck Med Univ, Dept Hyg Microbiol & Social Med, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria
关键词
Diagnosis; Mucorales; Zygomycetes; zygomycosis; CARE CANCER CENTER; FUNGAL-INFECTIONS; HEMATOLOGIC MALIGNANCIES; TERTIARY; ASPERGILLOSIS; MUCORMYCOSIS; EPIDEMIOLOGY; VORICONAZOLE; WORKLOAD; AUTOPSY;
D O I
10.1111/j.1469-0691.2009.02999.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
P>A definitive diagnosis of zygomycosis caused by Mucorales can be made by histopathological examination with or without isolation of the fungus from the same site. Histopathological examination of the tissues affected typically shows characteristic broad, hyaline, ribbon-like, irregular fungal hyphae with wide-angle branching, accompanied by tissue necrosis and angioinvasion of the fungi. Tissue invasion by the fungal hyphae as seen by microscopy is essential to establish the diagnosis. Fungal elements can be stained with Gomori methenamine-silver, periodic acid-Schiff or Calcoflour white stain. All Mucorales grow rapidly on most fungal media such as Sabouraud dextrose agar incubated at 25-30 degrees C. Mucorales from a sterile site or repeated positive cultures of the fungi from a non-sterile site are considered significant in a high-risk patient with predisposing factors for acquisition of zygomycosis. Positive cultures from non-sterile specimens should be interpreted with caution and will require correlation between the finding and the clinical situation.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 33 条
  • [1] Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature
    Almyroudis, N. G.
    Sutton, D. A.
    Linden, P.
    Rinaldi, M. G.
    Fung, J.
    Kusne, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) : 2365 - 2374
  • [2] Branscomb R, 2002, LAB MED, V33, P455
  • [3] Ten years' experience in zygomycosis at a tertiary care centre in India
    Chakrabarti, A
    Das, A
    Sharma, A
    Panda, N
    Das, S
    Gupta, KL
    Sakhuja, V
    [J]. JOURNAL OF INFECTION, 2001, 42 (04) : 261 - 266
  • [4] Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
    Chamilos, G
    Marom, EM
    Lewis, RE
    Lionakis, MS
    Kontoyiannis, DP
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) : 60 - 66
  • [5] Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986
  • [6] Zygomycosis: the re-emerging fungal infection
    Chayakulkeeree, M.
    Ghannoum, M. A.
    Perfect, J. R.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (04) : 215 - 229
  • [7] *ESCMID EUCAST SUB, CLIN MICROBIOL INFEC, V14, P982
  • [8] The changing face of fungal infections in health care settings
    Fridkin, SK
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (10) : 1455 - 1460
  • [9] The role of BAL in the diagnosis of pulmonary mucormycosis
    Glazer, M
    Nusair, S
    Breuer, R
    Lafair, J
    Sherman, Y
    Berkman, N
    [J]. CHEST, 2000, 117 (01) : 279 - 282
  • [10] In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species
    Guinea, Jesus
    Pelaez, Teresa
    Recio, Sandra
    Torres-Narbona, Marta
    Bouza, Emilio
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1396 - 1400